Literature DB >> 21380503

Cytokine production by leukocytes of Papillon-Lefèvre syndrome patients in whole blood cultures.

Christian D Sadik1, Barbara Noack, Beate Schacher, Josef Pfeilschifter, Heiko Mühl, Peter Eickholz.   

Abstract

Papillon-Lefèvre syndrome (PLS) is characterised by aggressively progressive periodontitis combined with palmo-plantar hyperkeratosis. It is caused by "loss of function" mutations in the cathepsin C gene. The hypothesis behind this study is that PLS patients' polymorphonuclear leukocytes (PMNs) produce more proinflammatory cytokines to compensate for their reduced capacity to neutralize leukotoxin and to eliminate Aggregatibacter actinomycetemcomitans. Production of more interleukin (IL)-8 would result in the attraction of more PMNs. The aim of this study was to evaluate the cytokine profile in PLS patients' blood cultures. Blood was sampled from eight PLS patients (one female) from six families (antiinfective therapy completed: six; edentulous: two) with confirmed cathepsin C mutations and deficient enzyme activity. Nine healthy males served as controls. Whole blood cultures were stimulated with highly pure lipopolysaccharide (LPS) from Escherichia coli R515 and IL-1β plus tumor necrosis factor (TNF)-α. Thereafter, release of IL-1β (stimulation: LPS and LPS plus adenosine triphosphate), IL-6, IL-8, interferon-inducible protein (IP)-10, and interferon (IFN)-γ (stimulation: LPS, IL-1β/TNFα) were detected by ELISA. Medians of cytokine release were, with the exception of IP-10, slightly higher for PLS than for controls' cultures. None of these differences reached statistical significance. Increased production of IL-1β, IL-6, IL-8, IP-10, or IFNγ as a significant means to compensate for diminished activity and stability of polymorphonuclear leukocyte-derived proteases could not be confirmed in this study. Cytokine profiles in blood cultures may not be used to identify PLS patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21380503     DOI: 10.1007/s00784-011-0532-0

Source DB:  PubMed          Journal:  Clin Oral Investig        ISSN: 1432-6981            Impact factor:   3.573


  49 in total

Review 1.  Pyogenic liver abscess and Papillon-Lefèvre syndrome: not a rare association.

Authors:  Maha Almuneef; Sultan Al Khenaizan; Sulaiman Al Ajaji; Abdullah Al-Anazi
Journal:  Pediatrics       Date:  2003-01       Impact factor: 7.124

2.  A family with Papillon-Lefevre syndrome reveals a requirement for cathepsin C in granzyme B activation and NK cell cytolytic activity.

Authors:  Josephine L Meade; Erika A de Wynter; Peter Brett; Saghira Malik Sharif; C Geoffrey Woods; Alexander F Markham; Graham P Cook
Journal:  Blood       Date:  2006-01-12       Impact factor: 22.113

3.  Palmar plantar keratosis and unusual periodontal findings. Observations from a family of 4 members.

Authors:  O Fardal; E Drangsholt; I Olsen
Journal:  J Clin Periodontol       Date:  1998-02       Impact factor: 8.728

4.  Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis.

Authors:  C Toomes; J James; A J Wood; C L Wu; D McCormick; N Lench; C Hewitt; L Moynihan; E Roberts; C G Woods; A Markham; M Wong; R Widmer; K A Ghaffar; M Pemberton; I R Hussein; S A Temtamy; R Davies; A P Read; P Sloan; M J Dixon; N S Thakker
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

Review 5.  Destructive and protective roles of cytokines in periodontitis: a re-appraisal from host defense and tissue destruction viewpoints.

Authors:  G P Garlet
Journal:  J Dent Res       Date:  2010-08-25       Impact factor: 6.116

6.  Role of polymorphonuclear leukocyte-derived serine proteinases in defense against Actinobacillus actinomycetemcomitans.

Authors:  Susanne F de Haar; Pieter S Hiemstra; Martijn T J M van Steenbergen; Vincent Everts; Wouter Beertsen
Journal:  Infect Immun       Date:  2006-09       Impact factor: 3.441

7.  Orthodontic treatment in a patient with Papillon-Lefèvre syndrome.

Authors:  Christopher J Lux; Birgit Kugel; Gerda Komposch; Sabine Pohl; Peter Eickholz
Journal:  J Periodontol       Date:  2005-04       Impact factor: 6.993

8.  Treatment of Papillon-Lefèvre syndrome periodontitis.

Authors:  J J Pacheco; C Coelho; F Salazar; A Contreras; J Slots; C H Velazco
Journal:  J Clin Periodontol       Date:  2002-04       Impact factor: 8.728

9.  Clinical, bacteriological, and immunological examinations and the treatment process of two Papillon-Lefèvre syndrome patients.

Authors:  I Ishikawa; M Umeda; N Laosrisin
Journal:  J Periodontol       Date:  1994-04       Impact factor: 6.993

10.  The role of cathepsin C in Papillon-Lefèvre syndrome, prepubertal periodontitis, and aggressive periodontitis.

Authors:  Chelsee Hewitt; Derek McCormick; Gerry Linden; Dusan Turk; Igor Stern; Ian Wallace; Louise Southern; Liqun Zhang; Rebecca Howard; Pedro Bullon; Melanie Wong; Richard Widmer; Khaled Abdul Gaffar; Lama Awawdeh; Jim Briggs; Reza Yaghmai; Ethlin W Jabs; Peter Hoeger; Oliver Bleck; Stefan G Rüdiger; Gregor Petersilka; Maurizio Battino; Peter Brett; Faiez Hattab; Mohamed Al-Hamed; Philip Sloan; Carmel Toomes; Mike Dixon; Jacqueline James; Andrew P Read; Nalin Thakker
Journal:  Hum Mutat       Date:  2004-03       Impact factor: 4.878

View more
  2 in total

1.  Papillon-Lefevre Syndrome In An Adolescent Female: A Case Study.

Authors:  M J Jijin; H P Jaishankar; Veena Sathya Narayaran; Krupashankar Rangaswamy; Kavitha Ankanathapura Puthaswamy
Journal:  J Clin Diagn Res       Date:  2015-05-01

2.  Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice.

Authors:  Karla G G Serafim; Suelen A Navarro; Ana C Zarpelon; Felipe A Pinho-Ribeiro; Victor Fattori; Thiago M Cunha; Jose C Alves-Filho; Fernando Q Cunha; Rubia Casagrande; Waldiceu A Verri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-08-06       Impact factor: 3.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.